Nonprofit Organizations
New Funding Opportunity Through the Conexiones Positivas Fund/Nueva oportunidad de financiamiento a traves del Fondo Conexiones Positivas
The Conexiones Positivas Fund seeks to address these disparities faced by Latine communities by supporting organizations, initiatives, and innovations led by and serving Latines living with and vulnerable to HIV through HIV care and prevention services, advocacy and movement-building, stigma reduction, and leadership development. We aim to enhance collaborations between traditional HIV-focused organizations and those with a background in addressing the compounding social justice and civil rights issues that affect these health outcomes, even if they have limited prior experience with HIV.
New Funding Opportunity Through the Conexiones Positivas Fund/Nueva oportunidad de financiamiento a traves del Fondo Conexiones Positivas
The Conexiones Positivas Fund seeks to address these disparities faced by Latine communities by supporting organizations, initiatives, and innovations led by and serving Latines living with and vulnerable to HIV through HIV care and prevention services, advocacy and movement-building, stigma reduction, and leadership development. We aim to enhance collaborations between traditional HIV-focused organizations and those with a background in addressing the compounding social justice and civil rights issues that affect these health outcomes, even if they have limited prior experience with HIV.
Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)
This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficult to target via traditional drug discovery methodologies.
Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficult to target via traditional drug discovery methodologies.
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use.
The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)
Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support pilot/exploratory research that expands the current understanding of the confluence of cancer stigma and HIV stigma among people with HIV (PWH) diagnosed with cancer; assesses the impact of these two converging stigmas on cancer outcomes among PWH with cancer; leverages stigma reduction interventions at multiple levels to intervene on modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer; and promotes resear